Real-time enrollment status for this retroperitoneal sarcoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 9:52 PM UTC
| NCT Number | NCT04031677 |
| Recruiting Status | Recruiting |
| Condition | Retroperitoneal Sarcoma |
| Phase | PHASE3 |
| Target Enrollment | 250 participants |
| Active Locations | 116 sites in the US |
| Sponsor | European Organisation for Research and Treatment of Cancer - EORTC |
| Last Updated on CT.gov | October 7, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT04031677 is currently recruiting participants. This phase3 study for retroperitoneal sarcoma is actively seeking new participants at 116 locations across the United States. The study is sponsored by European Organisation for Research and Treatment of Cancer - EORTC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04031677 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 116 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04031677 was last updated 1 week ago (October 7, 2026). HelloStudys verifies this status automatically.